cp 424391 has been researched along with glucagon in 2 studies
| Studies (cp 424391) | Trials (cp 424391) | Recent Studies (post-2010) (cp 424391) | Studies (glucagon) | Trials (glucagon) | Recent Studies (post-2010) (glucagon) |
|---|---|---|---|---|---|
| 34 | 7 | 20 | 26,039 | 1,498 | 3,054 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Crakes, KR; Gilor, C; Greathouse, RL; Huising, MO; Miller, M; Pires, J; Quach, N | 1 |
| Castro, RA; Gilor, C; Hill, RC; O'Kell, AL; Pascutti, KM; Salute, ME | 1 |
2 other study(ies) available for cp 424391 and glucagon
| Article | Year |
|---|---|
The effect of the ghrelin-receptor agonist capromorelin on glucose metabolism in healthy cats.
Topics: Animals; Blood Glucose; Cats; Glucagon; Glucose; Glucose Tolerance Test; Insulin; Insulin Resistance; Male; Piperidines; Pyrazoles; Receptors, Ghrelin | 2021 |
The effect of capromorelin on glycemic control in healthy dogs.
Topics: Animals; Blood Glucose; Blood Glucose Self-Monitoring; Cats; Dogs; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucose; Glycemic Control; Insulin; Piperidines; Prospective Studies; Pyrazoles | 2022 |